Left Ventricular Assist Device Ups QoL in Ambulatory Heart Failure
Left ventricular assist devices increase quality-adjusted life-years, readmissions, and costs
Modest Links for Systemic Medication Use, IOP in Glaucoma
Systemic β-blocker use linked to lower IOP; ACEI, ARB, statin, sulfonylurea linked to higher IOP
Concussions May Accelerate Alzheimer’s Disease Progression
Brain trauma seems to speed up mental decline in patients at genetic risk for Alzheimer's
Pace of Influenza Activity Picking Up Across the United States
Dominant strain right now is H3N2, CDC epidemiologist notes
PCP Involvement Tied to End-of-Life Care Patterns
Higher primary care physician involvement linked to less intensive and lower cost end-of-life care
No Cognitive Benefit for Long-Term Lifestyle Intervention
Long-term weight-loss intervention had no cognitive benefit in overweight, obese adults with diabetes
β-Blockers Linked to Reduced Mortality in HFrEF, A-Fib
Reduction in all-cause mortality, but not hospitalization, regardless of pattern, burden of a-fib
New Comprehensive Report Looks at Benefits, Harms of Cannabis
Can ease chronic pain, chemo-related nausea, muscle spasms in MS, but researchers cite risks, too
Sitagliptin Has Neutral CV Risk Effect in Elderly With T2DM, CVD
Neutral effects on cardiovascular risk among older patients with well-controlled T2DM and CVD
Excessive FDA Regulation Driving High Drug Prices
First-in-class drugs are fast-tracked while follow-on drugs can take up to 15 years to be approved
